REPLICEL LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0428 USD | +4.99% |
|
-.--% | -4.89% |
| Apr. 18 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
| 2023 | RepliCel Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Performance
| 1 day | +4.99% | ||
| 3 months | +4.90% | ||
| 6 months | -3.39% | ||
| Current year | -4.89% | ||
| 1 year | -61.61% | ||
| 3 years | -87.37% | ||
| 5 years | -85.19% | ||
| 10 years | -99.35% |
Volumes
marketsDaily volume
550
Estimated daily volume
550
Record volume 1
429 181
Record volume 2
382 627
Record volume 3
315 643
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
2 784 341
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
39.48 %
Free-Float capitalization (USD)
1 038 743
Highs and lows
Current year
0.03
0.07
1 year
0.030.19
3 years
0.030.34
5 years
0.030.47
10 years
0.036.50
Indicators
Moving average 5 days
0.04
Moving average 20 days
0.04
Moving average 50 days
0.05
Moving average 100 days
0.05
Price spread / (MMA5)
+1.32%
Price spread / (MMA20)
-7.09%
Price spread / (MMA50)
+5.29%
Price spread / (MMA100)
+16.49%
RSI 9 days
50.91
RSI 14 days
50.12
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.99% | -.--% | -4.89% | -61.61% | 2.78M | ||
| +1.04% | +5.31% | +9.42% | +30.48% | 114B | ||
| +1.48% | +0.87% | +11.84% | +31.04% | 104B | ||
| -2.55% | -1.16% | -14.15% | -13.83% | 22.41B | ||
| -1.45% | -2.58% | -1.05% | -8.28% | 22.28B | ||
| +0.74% | +1.90% | -5.29% | -28.18% | 19.07B | ||
| -1.49% | -1.04% | -38.29% | -34.78% | 18B | ||
| +1.06% | +7.27% | -4.16% | -25.17% | 17.89B | ||
| +0.27% | +4.09% | +7.99% | +49.35% | 14.28B | ||
| -1.02% | -0.33% | +36.24% | -11.69% | 12.55B | ||
| -2.61% | +4.44% | -24.95% | -36.71% | 8.45B | ||
| -1.17% | +14.39% | +18.74% | +54.77% | 8.21B | ||
| -3.43% | -3.57% | -52.50% | -69.89% | 7.76B | ||
| -0.59% | -0.21% | -0.71% | +32.89% | 7.72B | ||
| -2.98% | -9.02% | +260.02% | +174.48% | 7.62B | ||
| -1.37% | -9.25% | -3.83% | +33.69% | 7.04B | ||
| Average | -0.59% | +0.55% | +12.15% | +7.28% | ||
| Weighted average by Cap. | +0.03% | +1.50% | +8.06% | +16.80% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -4.81% | ||
| 2023 | -12.45% | ||
| 2022 | -71.65% | ||
| 2021 | +6.58% | ||
| 2020 | -22.58% | ||
| 2019 | -17.03% | ||
| 2018 | -14.58% | ||
| 2017 | -56.34% | ||
| 2016 | -63.21% | ||
| 2015 | -40.43% | ||
| 2014 | -34.55% | ||
| 2013 | +7.61% | ||
| 2012 | -80.43% | ||
| 2011 | +34.29% | ||
| 2010 | +12.90% |
- Stock Market
- Equities
- REPCF Stock
- Quotes RepliCel Life Sciences Inc.
